Human organ chips enable COVID-19 drug repurposing
Students develop glove-based sensor for those with trichotillomania
3 May 2021Scientists invent cryomicroneedles for intradermal therapeutic cell delivery
3 May 2021Human organ chips enable COVID-19 drug repurposing
A Wyss Institute-led collaboration spanning four research labs and hundreds of miles has used the Institute’s organ-on-a-chip (Organ Chip) technology to identify the antimalarial drug amodiaquine as a potent inhibitor of infection with SARS-CoV-2, the virus that causes COVID-19.
